PANION & BF BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.1 TWD | -1.42% |
|
-3.86% | -13.30% |
| Mar. 14 | Panion & Bf Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 07 | Panion & Bf Biotech Inc. Approves Cash Dividend for 2023 | CI |
| Sales 2022 | 2.4B 73.64M | Sales 2023 | 1.88B 57.77M | Capitalization | 9.6B 295M |
|---|---|---|---|---|---|
| Net income 2022 | 182M 5.59M | Net income 2023 | 77M 2.36M | EV / Sales 2022 | 6.41 x |
| Net Debt 2022 | 34.7M 1.07M | Net Debt 2023 | 225M 6.89M | EV / Sales 2023 | 5.22 x |
| P/E ratio 2022 |
84.4
x | P/E ratio 2023 |
124
x | Employees | - |
| Yield 2022 |
1.12% | Yield 2023 |
1.34% | Free-Float | 68.48% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.42% | ||
| 1 week | -3.86% | ||
| Current month | -11.73% | ||
| 1 month | -8.83% | ||
| 3 months | -6.18% | ||
| 6 months | -6.18% | ||
| Current year | -13.30% |
1 week
96.40
99.20
1 month
94.80115.00
Current year
94.80116.00
1 year
90.30170.00
3 years
63.10195.00
5 years
49.80195.00
10 years
26.05342.02
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 80-02-29 | |
Feng Jen Wang
DFI | Director of Finance/CFO | - | 00-01-10 |
Er Kun Ding
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 80-02-29 | |
Te Fu Hsieh
BRD | Director/Board Member | - | 01-05-17 |
Li Chiu Chang
CHM | Chairman | - | 16-06-02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 97.1 | -1.42% | 457,283 |
| 24-04-24 | 98.5 | 0.00% | 302,443 |
| 24-04-23 | 98.5 | +1.44% | 423,356 |
| 24-04-22 | 97.1 | +0.83% | 432,595 |
| 24-04-19 | 96.3 | -4.65% | 1,312,531 |
End-of-day quote Taiwan S.E., April 24, 2024
More quotes
PANION & BF BIOTECH INC. is a Taiwan-based company principally engaged in the manufacture and sales of western medicines and experimental drugs. The Company is also involved in the manufacture and sales of various kinds of cosmetics. The Company's products also include formula food, medical devices, animal drugs, pet drugs, feed and environmental health drugs. The Company also provides biotechnology services. The Company distributes its products in Taiwan market and to the mainland China, Hong Kong and Macau markets.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -13.30% | 255M | |
| +24.17% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.45% | 233B | |
| +6.04% | 201B | |
| -10.51% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
- Stock Market
- Equities
- 1760 Stock
